low debt

  1. A

    Use case study of Sun Pharma.

    Hi, I needed your views on a caes study of Sun Pharma. It is a Nifty50 stock. However below are the points PROS - It is Nifty 50 which is +ve - It has reduced debt which is +ve CONS - It has low return on equity of 9.77% for last 3 years. - The company has delivered a poor growth of 3.69% over...